8-Substituted 3,4-dihydroquinolinones as a novel scaffold for atypical antipsychotic activity

Jamie M. Singer, Bridget M. Barr, Linda L. Coughenour, Tracy F. Gregory, Michael A. Walters

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

Several new, potent dopamine subtype 2 (DA D2) active compounds with serotonin subtype 2A (5-HT2A) pharmacology are presented. 8-Substituted 3,4-dihydroquinolinones, tetrahydroquinolines, and N-acyl tetrahydroquinolines were evaluated in primary assays. Subtle changes on this novel scaffold translated to large changes in potency and selectivity in vitro. These compounds show promise as novel atypical antipsychotics for the treatment of schizophrenia.

Original languageEnglish
Pages (from-to)4560-4563
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume15
Issue number20
DOIs
StatePublished - Oct 15 2005

Keywords

  • Atypical Antipsychotics
  • Dopamine
  • Serotonin

Fingerprint

Dive into the research topics of '8-Substituted 3,4-dihydroquinolinones as a novel scaffold for atypical antipsychotic activity'. Together they form a unique fingerprint.

Cite this